Flash Glucose Monitoring and Diabetes Mellitus Induced by Immune Checkpoint Inhibitors: An Approach to Clinical Practice.

Authors:
Rodríguez de Vera-Gómez P; Piñar-Gutiérrez A; Guerrero-Vázquez R; Bellido V; Morales-Portillo C and 6 more

Journal:
J Diabetes Res

Publication Year: 2022

DOI:
10.1155/2022/4508633

PMCID:
PMC9652069

PMID:
36387939

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Diabetes Res

Abbreviation: J Diabetes Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advances in Research Related to MicroRNA for Diabetic Retinopathy.
Luo Y; Li C. (2024) - Transparency Score: 3/6
Beneficial Effects of Ursodeoxycholic Acid on Metabolic Parameters and Oxidative Stress in Patients…
Lakić B; Škrbić R; Uletilović S and 9 more (2024) - Transparency Score: 3/6
Does Pre-existing Diabetes Correlate with Long COVID-19 in Europe? Evidence from the Analysis of th…
Cuschieri S; Wilk P. (2024) - Transparency Score: 3/6
Huaju Xiaoji Formula Regulates ERS-lncMGC/miRNA to Enhance the Renal Function of Hypertensive Diabe…
Zhang Z; Fu X; Zhou F and 7 more (2024) - Transparency Score: 3/6
Pathology of Ketoacidosis in Emergency of Diabetic Ketoacidosis and Alcoholic Ketoacidosis: A Retro…
Koyama K; Anno T; Kimura Y and 4 more (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare no conflicts of interest."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025